{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:30:20Z","timestamp":1790692220510,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Key Science and Technology Research Project in Henan Province","award":["No. 222102310511"],"award-info":[{"award-number":["No. 222102310511"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"DOI":"10.1186\/s13148-025-02000-0","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T11:16:29Z","timestamp":1763464589000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["HMGA1 drives EMT in obliterative bronchiolitis through epigenetic regulation of chromatin accessibility in pulmonary epithelial cells"],"prefix":"10.1186","volume":"17","author":[{"given":"Tian","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoyao","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sihua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wantong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"issue":"Suppl 14","key":"2000_CR1","doi-asserted-by":"publisher","first-page":"S1810","DOI":"10.21037\/jtd.2019.06.31","volume":"11","author":"DC Nguyen","year":"2019","unstructured":"Nguyen DC, Loor G, Carrott P, Shafii A. Review of donor and recipient surgical procedures in lung transplantation. J Thorac Dis. 2019;11(Suppl 14):S1810-s1816. https:\/\/doi.org\/10.21037\/jtd.2019.06.31.","journal-title":"J Thorac Dis"},{"issue":"2 Suppl 2","key":"2000_CR2","doi-asserted-by":"publisher","first-page":"S324","DOI":"10.1016\/j.jaci.2009.11.014","volume":"125","author":"J Chinen","year":"2010","unstructured":"Chinen J, Buckley RH. Transplantation immunology: solid organ and bone marrow. J Allergy Clin Immunol. 2010;125(2 Suppl 2):S324-335. https:\/\/doi.org\/10.1016\/j.jaci.2009.11.014.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"2000_CR3","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.ejcts.2006.09.027","volume":"30","author":"I Al-Githmi","year":"2006","unstructured":"Al-Githmi I, Batawil N, Shigemura N, Hsin M, Lee TW, He GW, et al. Bronchiolitis obliterans following lung transplantation. Eur J Cardiothorac Surg. 2006;30(6):846\u201351. https:\/\/doi.org\/10.1016\/j.ejcts.2006.09.027.","journal-title":"Eur J Cardiothorac Surg"},{"key":"2000_CR4","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00185-2022","author":"AR Glanville","year":"2022","unstructured":"Glanville AR, Benden C, Bergeron A, Cheng GS, Gottlieb J, Lease ED, et al. Bronchiolitis obliterans syndrome after lung or haematopoietic stem cell transplantation: current management and future directions. ERJ Open Res. 2022. https:\/\/doi.org\/10.1183\/23120541.00185-2022.","journal-title":"ERJ Open Res"},{"issue":"1 Pt 1","key":"2000_CR5","first-page":"1","volume":"15","author":"SA Yousem","year":"1996","unstructured":"Yousem SA, Berry GJ, Cagle PT, Chamberlain D, Husain AN, Hruban RH, et al. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: lung rejection study group. J Heart Lung Transplant. 1996;15(1 Pt 1):1\u201315.","journal-title":"J Heart Lung Transplant"},{"issue":"9","key":"2000_CR6","doi-asserted-by":"publisher","first-page":"3476","DOI":"10.1016\/j.transproceed.2011.09.037","volume":"43","author":"S De Vleeschauwer","year":"2011","unstructured":"De Vleeschauwer S, Vanaudenaerde B, Vos R, Meers C, Wauters S, Dupont L, et al. The need for a new animal model for chronic rejection after lung transplantation. Transplant Proc. 2011;43(9):3476\u201385. https:\/\/doi.org\/10.1016\/j.transproceed.2011.09.037.","journal-title":"Transplant Proc"},{"issue":"6","key":"2000_CR7","first-page":"1945","volume":"142","author":"MI Hertz","year":"1993","unstructured":"Hertz MI, Jessurun J, King MB, Savik SK, Murray JJ. Reproduction of the obliterative bronchiolitis lesion after heterotopic transplantation of mouse airways. Am J Pathol. 1993;142(6):1945\u201351.","journal-title":"Am J Pathol"},{"issue":"3","key":"2000_CR8","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/rr55","volume":"2","author":"DJ Hele","year":"2001","unstructured":"Hele DJ, Yacoub MH, Belvisi MG. The heterotopic tracheal allograft as an animal model of obliterative bronchiolitis. Respir Res. 2001;2(3):169\u201383. https:\/\/doi.org\/10.1186\/rr55.","journal-title":"Respir Res"},{"issue":"3","key":"2000_CR9","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1006\/exmp.2002.2466","volume":"73","author":"B Naidu","year":"2002","unstructured":"Naidu B, Krishnadasan B, Whyte RI, Warner RL, Ward PA, Mulligan MS. Regulatory role of IL-10 in experimental obliterative bronchiolitis in rats. Exp Mol Pathol. 2002;73(3):164\u201370. https:\/\/doi.org\/10.1006\/exmp.2002.2466.","journal-title":"Exp Mol Pathol"},{"issue":"2","key":"2000_CR10","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1097\/01.tp.0000250579.08042.b6","volume":"83","author":"A Bharat","year":"2007","unstructured":"Bharat A, Narayanan K, Street T, Fields RC, Steward N, Aloush A, et al. Early posttransplant inflammation promotes the development of alloimmunity and chronic human lung allograft rejection. Transplantation. 2007;83(2):150\u20138. https:\/\/doi.org\/10.1097\/01.tp.0000250579.08042.b6.","journal-title":"Transplantation"},{"issue":"3","key":"2000_CR11","doi-asserted-by":"publisher","first-page":"e20190103","DOI":"10.1084\/jem.20190103","volume":"217","author":"N Frangogiannis","year":"2020","unstructured":"Frangogiannis N. Transforming growth factor-\u03b2 in tissue fibrosis. J Exp Med. 2020;217(3):e20190103. https:\/\/doi.org\/10.1084\/jem.20190103.","journal-title":"J Exp Med"},{"issue":"2","key":"2000_CR12","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/wrr.12398","volume":"24","author":"MK Lichtman","year":"2016","unstructured":"Lichtman MK, Otero-Vinas M, Falanga V. Transforming growth factor beta (TGF-\u03b2) isoforms in wound healing and fibrosis. Wound Repair Regen. 2016;24(2):215\u201322. https:\/\/doi.org\/10.1111\/wrr.12398.","journal-title":"Wound Repair Regen"},{"key":"2000_CR13","doi-asserted-by":"publisher","first-page":"110289","DOI":"10.1016\/j.cbi.2022.110289","volume":"369","author":"LL Ren","year":"2023","unstructured":"Ren LL, Li XJ, Duan TT, Li ZH, Yang JZ, Zhang YM, et al. Transforming growth factor-\u03b2 signaling: From tissue fibrosis to therapeutic opportunities. Chem Biol Interact. 2023;369:110289. https:\/\/doi.org\/10.1016\/j.cbi.2022.110289.","journal-title":"Chem Biol Interact"},{"issue":"7","key":"2000_CR14","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1007\/s00421-010-1764-4","volume":"111","author":"Q Cui","year":"2011","unstructured":"Cui Q, Wang Z, Jiang D, Qu L, Guo J, Li Z. HGF inhibits TGF-\u03b21-induced myofibroblast differentiation and ECM deposition via MMP-2 in achilles tendon in rat. Eur J Appl Physiol. 2011;111(7):1457\u201363. https:\/\/doi.org\/10.1007\/s00421-010-1764-4.","journal-title":"Eur J Appl Physiol"},{"issue":"19","key":"2000_CR15","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1056\/nejm199411103311907","volume":"331","author":"WA Border","year":"1994","unstructured":"Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med. 1994;331(19):1286\u201392. https:\/\/doi.org\/10.1056\/nejm199411103311907.","journal-title":"N Engl J Med"},{"issue":"11","key":"2000_CR16","doi-asserted-by":"publisher","first-page":"4414","DOI":"10.7150\/ijbs.72952","volume":"18","author":"L Wang","year":"2022","unstructured":"Wang L, Zhang J, Xia M, Liu C, Zu X, Zhong J. High mobility group A1 (HMGA1): structure, biological function, and therapeutic potential. Int J Biol Sci. 2022;18(11):4414\u201331. https:\/\/doi.org\/10.7150\/ijbs.72952.","journal-title":"Int J Biol Sci"},{"key":"2000_CR17","doi-asserted-by":"publisher","first-page":"9369035","DOI":"10.1155\/2022\/9369035","volume":"2022","author":"G Liang","year":"2022","unstructured":"Liang G, Zeng M, Gao M, Xing W, Jin X, Wang Q, et al. lncRNA IGF2-AS regulates nucleotide metabolism by mediating HMGA1 to promote pyroptosis of endothelial progenitor cells in sepsis patients. Oxid Med Cell Longev. 2022;2022:9369035. https:\/\/doi.org\/10.1155\/2022\/9369035.","journal-title":"Oxid Med Cell Longev"},{"key":"2000_CR18","doi-asserted-by":"publisher","first-page":"123400","DOI":"10.1016\/j.ijbiomac.2023.123400","volume":"232","author":"CH Yu","year":"2023","unstructured":"Yu CH, Hsieh PL, Chao SC, Chen SH, Liao YW, Yu CC. XIST\/let-7i\/HMGA1 axis maintains myofibroblasts activities in oral submucous fibrosis. Int J Biol Macromol. 2023;232:123400. https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.123400.","journal-title":"Int J Biol Macromol"},{"key":"2000_CR19","doi-asserted-by":"publisher","first-page":"666422","DOI":"10.3389\/fcell.2021.666422","volume":"9","author":"Q Xie","year":"2021","unstructured":"Xie Q, Yao Q, Hu T, Cai Z, Zhao J, Yuan Y, et al. High-mobility group A1 promotes cardiac fibrosis by upregulating FOXO1 in fibroblasts. Front Cell Dev Biol. 2021;9:666422. https:\/\/doi.org\/10.3389\/fcell.2021.666422.","journal-title":"Front Cell Dev Biol"},{"key":"2000_CR20","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3389\/fonc.2020.00294","volume":"10","author":"J Li","year":"2020","unstructured":"Li J, Peng W, Yang P, Chen R, Gu Q, Qian W, et al. MicroRNA-1224-5p inhibits metastasis and epithelial\u2013mesenchymal transition in colorectal cancer by targeting SP1-mediated NF-\u03baB signaling pathways. Front Oncol. 2020;10:294. https:\/\/doi.org\/10.3389\/fonc.2020.00294.","journal-title":"Front Oncol"},{"key":"2000_CR21","doi-asserted-by":"publisher","first-page":"216995","DOI":"10.1016\/j.canlet.2024.216995","volume":"597","author":"SY Li","year":"2024","unstructured":"Li SY, Zhang N, Zhang H, Wang N, Du YY, Li HN, et al. Deciphering the TCF19\/miR-199a-5p\/SP1\/LOXL2 pathway: Implications for breast cancer metastasis and epithelial\u2013mesenchymal transition. Cancer Lett. 2024;597:216995. https:\/\/doi.org\/10.1016\/j.canlet.2024.216995.","journal-title":"Cancer Lett"},{"key":"2000_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22136784","author":"BK Yoon","year":"2021","unstructured":"Yoon BK, Hwang N, Chun KH, Lee Y, Duarte TPM, Kim JW, et al. Sp1-induced FNBP1 drives rigorous 3D cell motility in EMT-type gastric cancer cells. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22136784.","journal-title":"Int J Mol Sci"},{"key":"2000_CR23","doi-asserted-by":"publisher","first-page":"109709","DOI":"10.1016\/j.cellsig.2020.109709","volume":"74","author":"PJ Yue","year":"2020","unstructured":"Yue PJ, Sun YY, Li YH, Xu ZM, Fu WN. MYCT1 inhibits the EMT and migration of laryngeal cancer cells via the SP1\/miR-629-3p\/ESRP2 pathway. Cell Signal. 2020;74:109709. https:\/\/doi.org\/10.1016\/j.cellsig.2020.109709.","journal-title":"Cell Signal"},{"key":"2000_CR24","doi-asserted-by":"publisher","first-page":"115344","DOI":"10.1016\/j.bcp.2022.115344","volume":"206","author":"H Zhang","year":"2022","unstructured":"Zhang H, Zhang G, Zhang J, Xiao M, Cui S, Wu S, et al. Transcription factor SP1 and oncoprotein PPP1R13L regulate nicotine-induced epithelial\u2013mesenchymal transition in lung adenocarcinoma via a feedback loop. Biochem Pharmacol. 2022;206:115344. https:\/\/doi.org\/10.1016\/j.bcp.2022.115344.","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"2000_CR25","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s10020-020-00174-2","volume":"26","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, Yan G, Lei J, Chen Y, Wang T, Gong J, et al. The SP1-12LOX axis promotes chemoresistance and metastasis of ovarian cancer. Mol Med. 2020;26(1):39. https:\/\/doi.org\/10.1186\/s10020-020-00174-2.","journal-title":"Mol Med"},{"issue":"3","key":"2000_CR26","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s10549-025-07695-6","volume":"211","author":"B Diao","year":"2025","unstructured":"Diao B, Cai Y, Song D, Hu Y, Xie B, Kan Y, et al. A potential therapeutic molecule target: lncRNA AK023507 inhibits the metastasis of breast cancer by regulating the WNT\/DOCK4\/\u03b2-catenin axis. Breast Cancer Res Treat. 2025;211(3):727\u201341. https:\/\/doi.org\/10.1007\/s10549-025-07695-6.","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"2000_CR27","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s13402-025-01057-6","volume":"48","author":"K Zhou","year":"2025","unstructured":"Zhou K, Ma X, Yan T, Hu L, Tian Y, Zheng H, et al. THEMIS2 contributes to ovarian cancer metastasis via DOCK4-mediated activation of Rap1 signaling. Cell Oncol (Dordr). 2025;48(4):961\u201378. https:\/\/doi.org\/10.1007\/s13402-025-01057-6.","journal-title":"Cell Oncol (Dordr)"},{"issue":"1","key":"2000_CR28","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3892\/ijo.2013.2154","volume":"44","author":"JS Bae","year":"2014","unstructured":"Bae JS, Noh SJ, Kim KM, Jang KY, Chung MJ, Kim DG, et al. Serum response factor induces epithelial to mesenchymal transition with resistance to sorafenib in hepatocellular carcinoma. Int J Oncol. 2014;44(1):129\u201336. https:\/\/doi.org\/10.3892\/ijo.2013.2154.","journal-title":"Int J Oncol"},{"issue":"12","key":"2000_CR29","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1038\/cdd.2014.109","volume":"21","author":"X Zhao","year":"2014","unstructured":"Zhao X, He L, Li T, Lu Y, Miao Y, Liang S, et al. SRF expedites metastasis and modulates the epithelial to mesenchymal transition by regulating miR-199a-5p expression in human gastric cancer. Cell Death Differ. 2014;21(12):1900\u201313. https:\/\/doi.org\/10.1038\/cdd.2014.109.","journal-title":"Cell Death Differ"},{"issue":"3","key":"2000_CR30","doi-asserted-by":"publisher","first-page":"e70023","DOI":"10.1002\/biof.70023","volume":"51","author":"L Shan","year":"2025","unstructured":"Shan L, Gu GJ, Xiang CC, Zuo ED, Lian L, Cheng X. The immunotherapeutic target ANLN promotes renal clear cell carcinoma by regulating PI3K\/Akt and P53 signaling pathways. BioFactors. 2025;51(3):e70023. https:\/\/doi.org\/10.1002\/biof.70023.","journal-title":"BioFactors"},{"issue":"6","key":"2000_CR31","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1183\/09031936.03.00039103","volume":"22","author":"A Boehler","year":"2003","unstructured":"Boehler A, Estenne M. Post-transplant bronchiolitis obliterans. Eur Respir J. 2003;22(6):1007\u201318. https:\/\/doi.org\/10.1183\/09031936.03.00039103.","journal-title":"Eur Respir J"},{"issue":"10","key":"2000_CR32","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1038\/nbt.1685","volume":"28","author":"A Portela","year":"2010","unstructured":"Portela A, Esteller M. Epigenetic modifications and human disease. Nat Biotechnol. 2010;28(10):1057\u201368. https:\/\/doi.org\/10.1038\/nbt.1685.","journal-title":"Nat Biotechnol"},{"issue":"3","key":"2000_CR33","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/0168-9525(94)90232-1","volume":"10","author":"R Grosschedl","year":"1994","unstructured":"Grosschedl R, Giese K, Pagel J. HMG domain proteins: architectural elements in the assembly of nucleoprotein structures. Trends Genet. 1994;10(3):94\u2013100. https:\/\/doi.org\/10.1016\/0168-9525(94)90232-1.","journal-title":"Trends Genet"},{"issue":"5","key":"2000_CR34","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/0092-8674(92)90554-p","volume":"71","author":"D Thanos","year":"1992","unstructured":"Thanos D, Maniatis T. The high mobility group protein HMG I(Y) is required for NF-kappa B-dependent virus induction of the human IFN-beta gene. Cell. 1992;71(5):777\u201389. https:\/\/doi.org\/10.1016\/0092-8674(92)90554-p.","journal-title":"Cell"},{"key":"2000_CR35","doi-asserted-by":"publisher","first-page":"7038834","DOI":"10.1155\/2022\/7038834","volume":"2022","author":"H Dong","year":"2022","unstructured":"Dong H, Xue T, Liu Y, He S, Yi Y, Zhang B, et al. Low molecular weight fucoidan inhibits pulmonary fibrosis in vivo and in vitro via antioxidant activity. Oxid Med Cell Longev. 2022;2022:7038834. https:\/\/doi.org\/10.1155\/2022\/7038834.","journal-title":"Oxid Med Cell Longev"},{"key":"2000_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20112733","author":"B Senigagliesi","year":"2019","unstructured":"Senigagliesi B, Penzo C, Severino LU, Maraspini R, Petrosino S, Morales-Navarrete H, et al. The high mobility group A1 (HMGA1) chromatin architectural factor modulates nuclear stiffness in breast cancer cells. Int J Mol Sci. 2019. https:\/\/doi.org\/10.3390\/ijms20112733.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2000_CR37","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1042\/bj20081427","volume":"418","author":"MA Grant","year":"2009","unstructured":"Grant MA, Baron RM, Macias AA, Layne MD, Perrella MA, Rigby AC. Netropsin improves survival from endotoxaemia by disrupting HMGA1 binding to the NOS2 promoter. Biochem J. 2009;418(1):103\u201312. https:\/\/doi.org\/10.1042\/bj20081427.","journal-title":"Biochem J"},{"key":"2000_CR38","doi-asserted-by":"publisher","first-page":"115582","DOI":"10.1016\/j.bcp.2023.115582","volume":"212","author":"X Chang","year":"2023","unstructured":"Chang X, Liu J, Yang Q, Gao Y, Ding X, Zhao J, et al. Targeting HMGA1 contributes to immunotherapy in aggressive breast cancer while suppressing EMT. Biochem Pharmacol. 2023;212:115582. https:\/\/doi.org\/10.1016\/j.bcp.2023.115582.","journal-title":"Biochem Pharmacol"},{"issue":"7","key":"2000_CR39","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.7150\/ijbs.95595","volume":"20","author":"JR Guo","year":"2024","unstructured":"Guo JR, He KY, Yuan JL, An W, Yin WT, Li QT, et al. HMGA1 sensitizes esophageal squamous cell carcinoma to mTOR inhibitors through the ETS1-FKBP12 axis. Int J Biol Sci. 2024;20(7):2640\u201357. https:\/\/doi.org\/10.7150\/ijbs.95595.","journal-title":"Int J Biol Sci"},{"key":"2000_CR40","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3389\/fcell.2014.00005","volume":"2","author":"N Ozturk","year":"2014","unstructured":"Ozturk N, Singh I, Mehta A, Braun T, Barreto G. HMGA proteins as modulators of chromatin structure during transcriptional activation. Front Cell Dev Biol. 2014;2:5. https:\/\/doi.org\/10.3389\/fcell.2014.00005.","journal-title":"Front Cell Dev Biol"}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-025-02000-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13148-025-02000-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-025-02000-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T11:16:30Z","timestamp":1763464590000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalepigeneticsjournal.biomedcentral.com\/articles\/10.1186\/s13148-025-02000-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2000"],"URL":"https:\/\/doi.org\/10.1186\/s13148-025-02000-0","relation":{},"ISSN":["1868-7083"],"issn-type":[{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"assertion":[{"value":"9 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were performed with the approval of the Animal Ethics Committee of Huazhong\u00a0University\u00a0of\u00a0Science\u00a0and\u00a0Technology and the procedures for Care and Use of Laboratory Animals in cancer research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"192"}}